Provides for the creation of a drug guide for seniors regarding the drugs commonly used by people over 62 years of age; provides that such guide will include functions and drug interactions.
Summary
A03107 would amend the New York elder law to require the director, working with the state board of pharmacy and after consulting the Department of Health, to prepare and publish a senior drug guide. The guide would explain the purpose, function, and common drug interactions of medications commonly used by people over age 62, and would also describe the effects of combining those medications with alcohol. It must include a prominent warning advising users not to start, stop, or change medication dosages without consulting a doctor or other healthcare practitioner.
The bill requires the guide to be made available on the director’s website and distributed free of charge through designated agencies, with copies also provided in the six most common non-English languages used by individuals with limited English proficiency in New York. Requests for more than ten copies could be charged a reasonable fee to cover reproduction and handling. The guide would need to be updated as necessary to keep the information accurate and relevant, and the act would take effect on September 1 following enactment.
Impact
The bill would add a new section 226 to the elder law, creating a state-run consumer education resource focused on medication safety for older adults. It would impose an administrative duty on the director, in coordination with pharmacy and health officials, to produce, maintain, and distribute the guide, but it does not create new prescribing rules, licensing requirements, or penalties. Its practical effect would be to expand public health outreach and multilingual access to drug information for seniors and caregivers.
Sentiment
Based on the bill text and the absence of recorded committee debate or votes, the measure appears to be framed as a straightforward consumer-protection and public-health initiative. The sponsor’s approach suggests a supportive posture toward improving medication literacy among older adults, especially by emphasizing clear warnings and language access. No recorded opposition, amendments, or roll-call votes are available in the provided materials, so there is no documented controversy in the available record.
Contention
No specific points of contention are reflected in the provided transcripts or voting history, because none are available. Potential areas of debate, based on the bill’s design, could include the administrative burden of producing and updating the guide, the cost of multilingual distribution, and whether the state should be responsible for medication education that may overlap with pharmacists’ and physicians’ roles. However, these concerns are not documented in the supplied materials.
Same As
Provides for the creation of a drug guide for seniors regarding the drugs commonly used by people over 62 years of age; provides that such guide will include functions and drug interactions.
Provides for the creation of a drug guide for seniors regarding the drugs commonly used by people over 62 years of age; provides that such guide will include functions and drug interactions.
Provides for the creation of a drug guide for seniors regarding the drugs commonly used by people over 62 years of age; provides that such guide will include functions and drug interactions.
Requires health plan coverage to include generic drugs and biosimilars where the wholesale acquisition cost of such generic drugs or biosimilars is lower than the brand drug's wholesale acquisition cost.
Prohibiting certain health insurers from requiring cost-sharing for nonopioid prescription drugs or providing less favorable coverage for such drug than that for opioid or narcotic prescription drugs for the treatment of pain.